Tech Company Financing Transactions
Nanosphere Funding Round
Allen & Company, Bain Capital Ventures and Brookside Capital participated in a $57 million Series D funding round for Nanosphere. The round was announced on 5/16/2006.
Transaction Overview
Company Name
Announced On
5/16/2006
Transaction Type
Venture Equity
Amount
$57,000,000
Round
Series D
Investors
Proceeds Purpose
The company will use the proceeds to commercialize the Verigene System�, a platform for user-friendly, cost-effective direct genomic testing that eliminates the need for Polymerase Chain Reaction (PCR), and to continue development and commercialization of its proprietary Biobarcode� technology for ultra-sensitive detection of proteins and nucleic acids.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
4088 Commercial Avenue
Northbrook, IL 60062
USA
Northbrook, IL 60062
USA
Phone
Website
Email Address
Overview
Nanosphere, Inc. is a nanotechnology-based molecular diagnostics company, offering proprietary breakthrough technologies that provide a unique and powerful solution to greatly simplify molecular diagnostic testing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael McGarrity
Chief Financial Officer
Roger Moody
Browse more venture capital transactions:
Prev: 5/16/2006: D-Wave Systems venture capital transaction
Next: 5/16/2006: Zopa venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs